• Foreign Affairs
  • Money Matters
  • Domestic Affairs
  • IT, Innovation and Startups
 

Talk Finance

£$$€№₮IAL €¢¤₦¤MI¢ №€₩$
  • Foreign Affairs
  • Money Matters
  • Domestic Affairs
  • IT, Innovation and Startups

Talk Finance

  • Foreign Affairs
  • Money Matters
  • Domestic Affairs
  • IT, Innovation and Startups

In IT, Innovation and Startups

Tests of Oxford vaccine interrupted for safety data assessment

9th September 2020

Tests of Oxford vaccine interrupted for safety data assessment Pin It

The British Pharmaceutical AstraZeneca and the University of Oxford interrupt the advanced tests with a possible coronavirus vaccine for safety reasons, reports the health news website Stat News. The potential vaccine may have caused undesirable side effects in a subject. The European Commission and the Netherlands have made a deal with AstraZeneca for the vaccine developed by the pharmaceutical company with the University of Oxford.

“Standard assessment procedures have led to an interruption of vaccinations to assess the safety data,” says a spokesman for AstraZeneca in a statement. He says it’s a routine decision.

What undesirable effect has occurred in the subject and when it has occurred is not known. The subject is expected to recover.

An insider says that the tests have been shut down because of a”high degree of caution”. A second insider, who does not wish to be named and named, argues that the finding that led to the interruption affects the tests carried out by AstraZeneca, which have yet to be carried out, and those of other pharmacists carrying out vaccine trials.

A spokesman for AstraZeneca says that illness can always occur in large-scale trials. Individual cases which arise must then be examined carefully, according to the spokesman.

Nine major vaccine producers from Europe and the United States solemnly promised on Tuesday that they would not lower their normal safety standards, despite the great pressure that exists to quickly develop an effective vaccine. AstraZeneca also made that promise.

The tests on the so-called Oxford Vaccine, which are in the third phase, are currently mainly carried out in the United States. The test in which the undesirable side effects would have occurred took place in the United Kingdom.

Share

No Comments

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous Post

ECB pushes Brexit agenda

In Money Matters

ECB pushes Brexit agenda

View Post

Next Post

Bram Schot has been appointed…

In Money Matters

Bram Schot has been appointed Non-Executive Director of Shell

View Post

In Money Matters

Moody’s expects lower bounceback for Eurozone and Britain

View Post

In Money Matters

EU zone economic confidence reaches 93.4 with the reasons for euphoria still to uncover

View Post

In Money Matters

IAG advocates the digital ‘testing and vaccination passports’ for passengers

View Post

In Money Matters

Flat opening on Friday US markets

View Post

Newsletter

Latest News

View

The newly formed Stellantis counts on strong growth in sales

3rd March 2021

View

Rio Tinto chairman has left the company amid the ‘sacred cave’ destruction

3rd March 2021

View

In January 2021 Germany exported 30 percent less to the United Kingdom

2nd March 2021

View

COVID-19 made HelloFresh turnout skyrocket

2nd March 2021

Allow us to introduce ourselves

Talk-Finance.co.uk, the analytic media. We are focused on the fresh business, M&A and financial data. We pay attention to the interesting new projects and startups while not letting the whole picture to let unnoticed.

  • Investing.com
  • Runch.co.uk

Sign Up for Our Newsletter

Our friendly crew

  • Matthew Patridge, the chief Editor
  • Chris Kimble, the managing Editor
  • Matthew Weller, webmaster&technical stuff
  • Charles Sizemore, author
  • David Stevenson, author
  • Helen Rush, author

Contact us by [email protected]

© 2019 Talk Finance - All Rights Reserved. [email protected]